Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
Author(s) -
Jonathan A C Sterne,
Srinivas Murthy,
Janet Dı́az,
Arthur S. Slutsky,
Jesús Villar,
Derek C. Angus,
Djillali Annane,
Luciano César Pontes Azevedo,
Otávio Berwanger,
Alexandre Biasi Cavalcanti,
PierreFrançois Dequin,
Bin Du,
Jonathan Emberson,
David J. Fisher,
Bruno Giraudeau,
Anthony Gordon,
Anders Granholm,
Cameron Green,
Richard Haynes,
Nicholas Heming,
Julian P. T. Higgins,
Peter Horby,
Peter Jüni,
Martin Landray,
Amélie Le Gouge,
M Leclerc,
Wei Shen Lim,
F.S. Machado,
Colin McArthur,
Ferhat Meziani,
Morten Hylander Møller,
Anders Perner,
Marie Warrer Petersen,
Jelena Savović,
Bruno Martins Tomazini,
Viviane Cordeiro Veiga,
Steve Webb,
John C. Marshall
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2020.17023
Subject(s) - medicine , randomized controlled trial , meta analysis , odds ratio , placebo , observational study , clinical trial , pathology , alternative medicine
Effective therapies for patients with coronavirus disease 2019 (COVID-19) are needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced mortality in hospitalized patients with COVID-19 who required respiratory support.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom